Related Experiment Videos
Evaluation of polyvalent anti-Pseudomonas aeruginosa vaccine in phagocytic reaction
K Grzybek-Hryncewicz1, G Gościniak
1Department of Microbiology, Medical School, Wrocław.
Abstract:
In order to obtain immune reaction for all known Pseudomonas aeruginosa immunotypes (7 according to Fisher), mucoid and nonmucoid variants, rabbits were immunized with polyvalent vaccine consisting of 3 mucoid (1, 3, 5) and 4 nonmucoid (2, 4, 6, 7) immunotypes. The serum of immunized animals induced an increase in normal rabbit granulocyte phagocytosis level as well as intracellular killing of all Pseudomonas aeruginosa immunotypes, both mucoid and nonmucoid variants. The serum was also observed to have high agglutinin titer (1:1024-1:8192) for all the bacteria. While the cross affinity of the mucoid antigens in polyvalent vaccine it was possible to reduce by 4 the number of the mucoid antigens used for immunization.
Insights
A new polyvalent vaccine effectively elicits immune responses against all seven Pseudomonas aeruginosa immunotypes. This vaccine enhances granulocyte phagocytosis and intracellular killing of both mucoid and nonmucoid bacterial variants.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Pseudomonas aeruginosa presents diverse immunotypes, complicating vaccine development.
- Mucoid and nonmucoid variants exhibit distinct characteristics.
- Existing vaccines may not cover the full spectrum of P. aeruginosa strains.
Purpose of the Study:
- To develop a polyvalent vaccine for broad protection against Pseudomonas aeruginosa.
- To assess the immunogenicity of a combined mucoid and nonmucoid vaccine formulation.
- To evaluate the effectiveness of the vaccine in eliciting immune responses.
Main Methods:
- Immunization of rabbits with a polyvalent vaccine containing 3 mucoid and 4 nonmucoid P. aeruginosa immunotypes.
- Measurement of granulocyte phagocytosis and intracellular killing of P. aeruginosa.
- Determination of agglutinin titers in the serum of immunized rabbits.
Main Results:
- The polyvalent vaccine induced significant immune reactions against all 7 P. aeruginosa immunotypes.
- Serum from immunized rabbits demonstrated increased phagocytosis and intracellular killing of both mucoid and nonmucoid variants.
- High agglutinin titers (1:1024-1:8192) were observed against all tested bacteria.
- Cross-reactivity allowed a fourfold reduction in the number of mucoid antigens needed for immunization.
Conclusions:
- A polyvalent vaccine can effectively generate immune responses against diverse Pseudomonas aeruginosa strains.
- The developed vaccine shows promise for controlling infections caused by various P. aeruginosa immunotypes.
- Reducing antigen complexity in polyvalent vaccines is feasible due to cross-affinity.